Skip to main content
TipRanks
Go Ultimate75% OFF

Palatin Technologies (0KF3) Share Price & Analysis

3 Followers

0KF3 Stock Chart & Stats

$6.00-$0.73(-10.85%)
At close: 4:30 PM GMT
$5$7.5$10$12.5Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
$6.00 - $6.00
52-Week Range
$4.60 - $27.71
Previous Close
$6.73
Volume
N/A
Average Volume (3M)
54
Market Cap
$12.22M
Enterprise Value
$35.04M
Total Cash (Recent Filing)
$7.49M
Total Debt (Recent Filing)
$223.68K
Price to Earnings (P/E)
―
Beta
-0.57
Next Earnings
Nov 16, 2026 (Est.)
EPS Estimate
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

MC4R Pipeline Potential

The MC4R pipeline shows differentiated preclinical potential through strong weight-loss activity, selectivity and potentially infrequent dosing. If these characteristics translate into human studies, they could support patient adherence, broader use in rare obesity disorders and meaningful long-term product differentiation.

Partnered Revenue Platform

Partnered assets are already generating collaboration and licensing revenue, reducing reliance on internally funded commercialization and validating external interest in the portfolio. Boehringer milestone rights, royalties and reimbursed research could provide additional non-dilutive support as development advances.

Improving Loss And Cash Use

The reduction in net loss and operating cash consumption indicates improved financial performance versus the prior year, partly supported by collaboration revenue. Although PTN is not self-funding, lower cash use can extend available resources and improve flexibility while clinical programs progress.

Bears Say

Going-Concern Funding Risk

PTN’s operating plans depend on securing additional capital because existing cash is insufficient for at least twelve months. This creates a durable execution risk: development timing may slip, financing may be dilutive, and unfavorable funding terms could weaken shareholder value.

Persistent Cash Burn And Losses

Persistent operating and free cash outflows show that PTN has not yet demonstrated a self-sustaining business model. Continued losses require recurring financing or partner support, limiting strategic flexibility and increasing the risk that valuable programs cannot be advanced at the planned pace.

MC4R Tolerability Risk

Nausea, vomiting and hyperpigmentation are established class challenges that could constrain adherence, labeling and commercial uptake of future MC4R therapies. These risks remain relevant through clinical development because long-term treatment requires a tolerable profile in chronically treated patients.

Palatin Technologies News

0KF3 FAQ

What was Palatin Technologies’s price range in the past 12 months?
Palatin Technologies lowest share price was $4.60 and its highest was $27.71 in the past 12 months.
What is Palatin Technologies’s market cap?
Palatin Technologies’s market cap is $12.22M.
When is Palatin Technologies’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Palatin Technologies’s earnings last quarter?
Palatin Technologies released its earnings results on Sep 28, 2026. The company reported -$1.11 earnings per share for the quarter, beating the consensus estimate of -$1.2 by $0.09.
Is Palatin Technologies overvalued?
According to Wall Street analysts Palatin Technologies’s price is currently Undervalued.
Does Palatin Technologies pay dividends?
Palatin Technologies pays a dividend of $0.285 which represents an annual dividend yield of ―. See more information on Palatin Technologies dividends here
What is Palatin Technologies’s EPS estimate?
Palatin Technologies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Palatin Technologies have?
Palatin Technologies has 1,780,939 shares outstanding.
What happened to Palatin Technologies’s price movement after its last earnings report?
Palatin Technologies reported an EPS of -$1.11 in its last earnings report, beating expectations of -$1.2. Following the earnings report the stock price went down -0.75%.
Which hedge fund is a major shareholder of Palatin Technologies?
Hedge funds hold Palatin Technologies shares: the largest hedge-fund position in Palatin Technologies is 949,351,936 shares, and hedge funds decreased their holdings by 58.6K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology